Mojca Adlesic

Current Position

Postdoctoral researcher

Academic Education

2000 - 2005

Master of Science in Molecular Biology, University of Gothenburg, Gothenburg, Sweden

Advanced Qualifications

2007 - 2010

PhD Degree in Biology, Institute of Cell Biology, Swiss Federal Institute of Technology (ETH Zürich), Zürich, Switzerland

Postgraduate Positions

2017 - present	Postdoctoral Scientist, ZTZ, Medical Center - University of Freiburg
2012 - 2016	Postdoctoral Scientist, Institute of Physiology, University of Zürich, Zürich, Switzerland

Link to all publications of Mojca Adlesic: PubMed

Publications on CRC 1453 funding

Mohl DA, Lagies S, Zodel K, Zumkeller M, Peighambari A, Ganner A, Plattner DA, Neumann-Haefelin E, Adlesic M, Frew IJ, Kammerer B. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells (2023). Seidel P, Rubarth A, Zodel K, Peighambari A, Neumann F, …, Adlesic M, …, Schell C, Börries M, …, Follo M, Albers J, Frew IJ. ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma. JCI Insight (2022). Hoefflin R, Harlander S, Abhari BA, Peighambari A, Adlesic M, …, Börries M, Köttgen A, Heikenwalder M, Frew IJ. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (2021).